1796641-10-5
Chemical Structure
Parimifasor
Synonym(s): LYC30937
- CAS No.: 1796641-10-5
- Formula:C18H11Cl2F4N5O
- Molecular Weight:460.21
IUPAC Name: (E)-3-chloro-N-(N'-(3-chloro-5-fluorophenyl)-N-(5-(trifluoromethyl)-1H-pyrazol-3-yl)carbamimidoyl)benzamide
InChIKey: GPLAWHGEODGIAW-UHFFFAOYSA-N
SMILES: O=C(C1=CC(Cl)=CC=C1)N/C(NC2=NNC(C(F)(F)F)=C2)=N/C3=CC(Cl)=CC(F)=C3
Biological Activity: Parimifasor (LYC-30937) is an orally active agent for inflammatory bowel disease. Parimifasor targets F1F0-ATPase. Parimifasor acts on respiratory complex V, slows ATP production and induces Apoptosis. Parimifasor can be used in the research of inflammatory bowel disease[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Parimifasor | 98.53% | Parimifasor (LYC-30937) is an orally active agent for inflammatory bowel disease. Parimifasor targets F1F0-ATPase. Parimifasor acts on respiratory complex V, slows ATP production and induces Apoptosis. Parimifasor can be used in the research of inflammatory bowel disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Parimifasor (Standard) | ≥98% | Parimifasor (Standard) is the analytical standard of Parimifasor (HY-109098). This product is intended for research and analytical applications. Parimifasor (LYC-30937) is an orally active agent for inflammatory bowel disease. Parimifasor targets F1F0-ATPase. Parimifasor acts on respiratory complex V, slows ATP production and induces Apoptosis. Parimifasor can be used in the research of inflammatory bowel disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
